Ergoteles’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-77,409
Closed -$2.86M 170
2023
Q2
$2.86M Sell
77,409
-11,288
-13% -$345K 0.14% 187
2023
Q1
$2.66M Buy
+88,697
New +$2.92M 0.1% 203
2022
Q4
Sell
-64,376
Closed -$1.59M 1490
2022
Q3
$1.59M Buy
+64,376
New +$2.12M 0.06% 340
2021
Q1
Sell
-16,240
Closed -$403K 823
2020
Q4
$403K Buy
16,240
+5,440
+50% +$129K 0.01% 489
2020
Q3
$226K Buy
+10,800
New +$208K 0.03% 427

Other funds holding CC

Ergoteles's CC Position: Q3 2023 in Review

Ergoteles sold out of Chemours (CC) in Q3 2023, closing a stake of 77,409 shares — an estimated $2.86M sold.

Ergoteles first reported a position in CC in Q3 2020 and held it in 5 quarters. The position peaked at $2.86M in Q2 2023. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Ergoteles reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 77,409 Chemours shares in Q3 2023, an estimated $2.86M.
  • Ergoteles first reported a position in Chemours in Q3 2020 and held it in 5 quarters.
  • Ergoteles's Chemours position peaked at $2.86M in Q2 2023.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.